CORE F: HISPANIC SATELLITE - ABSTRACT There were about 46 million Hispanics in the USA in 2010. Elderly Hispanics are at risk for dementia, due to Alzheimer's Disease (AD) and vascular risk factors. The UCSD ADRC's studies of aging and dementia among Hispanics aim to improve our understanding of AD and related disorders and to overcome barriers to effective assessment, diagnosis and treatment of early (and even preclinical) disease. The Satellite will support general research in aging and dementia, because subjects will undergo the same procedures, including biomarker studies and request for autopsy consent, as non-Hispanic subjects in the ADRC, and will contribute to research projects and clinical trials. In addition, the Satellite will support research into aspects unique to Hispanics, including 1) the influence of bilingualism and low education on diagnostic assessment and in cognitive reserve and dementia risk;2) genetic, vascular, and socio-economic risk factors for cognitive decline and dementia. Overall aims for the Hispanic Satellite in this ADRC renewal application are to: 1) Support research efforts by recruiting and following well-characterized Hispanic subjects with normal cognition, Mild Cognitive Impairment (MCI), and AD. The Satellite will follow about 100 subjects (the balance between continued recruitment and death and dropout). Subjects will undergo standard clinical characterization (including the Uniform Data Set procedures). Biological samples (DNA, plasma and CSF), MRI and other brain images will be obtained. A comprehensive database will be maintained. Subjects will continue to contribute to autopsy studies after death. Data, biosamples and brain imaging studies from Hispanic Satellite subjects will be integrated with those from non-Hispanics followed by the Clinical Core. 2) Interact widely with researchers at UCSD, the VA Medical Center, and nearby research institutions. In particular, support ongoing funded research studies on bilingualism and on brain imaging and cognitive changes in aging in relation to APOE genotype and vascular risk factors. 4) Provide data to the National Alzheimer's Coordinating Center, and DNA to NCRAD, and collaborate with other AD Centers, and with multi-Center research efforts related to AD and dementia. Subjects will be offered participation in clinical trials organized by the Alzheimer's Disease Cooperative Study (ADCS), the Dominantly Inherited Alzheimer Network (DIAN), and by pharmaceutical companies. 5) Continue to support innovative research and train new investigators, 6) Foster professional education and training, and to improve public knowledge and awareness about aging, vascular and other risk factors that influence cognitive health in aging and dementia risk among Hispanics. To provide innovative support efforts for patients and families affected by AD.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Zlatar, Zvinka Z; Muniz, Martha; Galasko, Douglas et al. (2017) Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults. J Gerontol B Psychol Sci Soc Sci :
Katsumata, Yuriko; Nelson, Peter T; Ellingson, Sally R et al. (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25
Li, Ge; Shofer, Jane B; Petrie, Eric C et al. (2017) Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimers Res Ther 9:48
Granholm, Eric L; Panizzon, Matthew S; Elman, Jeremy A et al. (2017) Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease. J Alzheimers Dis 56:1419-1428
Cronin, Peter; McCarthy, Michael J; Lim, Andrew S P et al. (2017) Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement 13:689-700
Huang, Timothy Y; Zhao, Yingjun; Jiang, Lu-Lin et al. (2017) SORLA attenuates EphA4 signaling and amyloid ?-induced neurodegeneration. J Exp Med 214:3669-3685
Galasko, Douglas R; Shaw, Leslie M (2017) Alzheimer disease: CSF biomarkers for Alzheimer disease - approaching consensus. Nat Rev Neurol 13:131-132
Jacobs, Diane M; Ard, M Colin; Salmon, David P et al. (2017) Potential implications of practice effects in Alzheimer's disease prevention trials. Alzheimers Dement (N Y) 3:531-535
Sano, Mary; Zhu, Carolyn W; Grossman, Hillel et al. (2017) Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data. J Am Geriatr Soc 65:2198-2204
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738

Showing the most recent 10 out of 854 publications